Found: 17
Select item for more details and to access through your institution.
Developmental delay in hypoxia-induced HO-1 expression predisposes to gut injury.
- Published in:
- Journal of Perinatal Medicine, 2012, v. 40, n. 2, p. 191, doi. 10.1515/jpm.2011.117
- By:
- Publication type:
- Article
The impact of time between surgery and adjuvant chemoradiotherapy in advanced oral cavity squamous cell carcinoma.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1393910
- By:
- Publication type:
- Article
Tolerability and efficacy of the cancer vaccine UV1 in patients with recurrent or metastatic PD-L1 positive head and neck squamous cell carcinoma planned for first-line treatment with pembrolizumab - the randomized phase 2 FOCUS trial.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1283266
- By:
- Publication type:
- Article
Targeted treatment in a case series of AR+, HRAS/PIK3CA co-mutated salivary duct carcinoma.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1107134
- By:
- Publication type:
- Article
pN status predicts outcomes in surgically treated pT1–pT2 patients of various disease stages with squamous cell carcinoma of the head and neck: a 17-year retrospective single center cohort study.
- Published in:
- European Archives of Oto-Rhino-Laryngology, 2018, v. 275, n. 11, p. 2787, doi. 10.1007/s00405-018-5108-z
- By:
- Publication type:
- Article
Quality of Life of Patients with Head and Neck Cancer Receiving Cetuximab, Fluorouracil, Cisplatin Comparing to Cetuximab, Fluorouracil, Cisplatin, and Docetaxel within the CEFCID Trial.
- Published in:
- Oncology Research & Treatment, 2022, v. 45, n. 6, p. 319, doi. 10.1159/000521415
- By:
- Publication type:
- Article
Targeted Therapy of Head and Neck Cancer.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 12, p. 780, doi. 10.1159/000452432
- By:
- Publication type:
- Article
Multiparametric Phenotyping of Circulating Tumor Cells for Analysis of Therapeutic Targets, Oncogenic Signaling Pathways and DNA Repair Markers.
- Published in:
- Cancers, 2022, v. 14, n. 11, p. 2810, doi. 10.3390/cancers14112810
- By:
- Publication type:
- Article
Predictors for Adherence to Treatment Strategies in Elderly HNSCC Patients.
- Published in:
- Cancers, 2022, v. 14, n. 2, p. 423, doi. 10.3390/cancers14020423
- By:
- Publication type:
- Article
Treatment Stratification in First-Line Recurrent or Metastatic Head and Neck Cancer, on Behalf of the EORTC Young Investigator Head and Neck Cancer Group.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.730785
- By:
- Publication type:
- Article
Pre-operative cellular dissociation grading in biopsies is highly predictive of post-operative tumour stage and patient outcome in head and neck squamous cell carcinoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Distinct immune evasion in APOBEC‐enriched, HPV‐negative HNSCC.
- Published in:
- International Journal of Cancer, 2020, v. 147, n. 8, p. 2293, doi. 10.1002/ijc.33123
- By:
- Publication type:
- Article
A phosphoarray platform is capable of personalizing kinase inhibitor therapy in head and neck cancers.
- Published in:
- International Journal of Cancer, 2018, v. 142, n. 1, p. 156, doi. 10.1002/ijc.31045
- By:
- Publication type:
- Article
Basal subtype is predictive for response to cetuximab treatment in patient-derived xenografts of squamous cell head and neck cancer.
- Published in:
- International Journal of Cancer, 2017, v. 141, n. 6, p. 1215, doi. 10.1002/ijc.30808
- By:
- Publication type:
- Article
A comprehensively characterized large panel of head and neck cancer patient-derived xenografts identifies the m TOR inhibitor everolimus as potential new treatment option.
- Published in:
- International Journal of Cancer, 2015, v. 136, n. 12, p. 2940, doi. 10.1002/ijc.29344
- By:
- Publication type:
- Article
Disulfiram Acts as a Potent Radio-Chemo Sensitizer in Head and Neck Squamous Cell Carcinoma Cell Lines and Transplanted Xenografts.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 3, p. 517, doi. 10.3390/cells10030517
- By:
- Publication type:
- Article
PI3K/PTEN/AKT/mTOR polymorphisms: Association with clinical outcome in patients with head and neck squamous cell carcinoma receiving cetuximab-docetaxel.
- Published in:
- Head & Neck, 2015, v. 37, n. 4, p. 471, doi. 10.1002/hed.23604
- By:
- Publication type:
- Article